Dongchul Cha

Yonsei University

Papers

4

Total Citations

109

H-Index

4

About

Dr. Dongchul Cha is a pioneering head and neck surgeon whose work centers on advancing transoral robotic surgery (TORS) for complex aerodigestive tract cancers. His major contributions lie in expanding the applications of TORS beyond standard indications, demonstrating its feasibility and oncologic safety in challenging scenarios. Notably, his 2017 study on TORS for hypopharyngeal cancer (48 citations) established long-term functional and oncological outcomes, proving the technique’s viability in this difficult anatomic site. Dr. Cha also led a landmark clinical trial (27 citations) integrating neoadjuvant chemotherapy with TORS and customized adjuvant therapy for advanced T3/T4 oropharyngeal cancer, pioneering a tailored, less morbid treatment paradigm. His technical innovations include the first detailed description of transoral robotic retropharyngeal lymph node dissection for tonsillar cancer (15 citations), providing a critical surgical roadmap for managing nodal metastases. Beyond oncology, Dr. Cha applied TORS to treat Eagle’s syndrome (19 citations), showcasing the versatility of robotic approaches for benign conditions. His work has collectively garnered over 100 citations, reflecting its significant impact on refining minimally invasive surgical strategies that improve both survival and quality of life for patients with head and neck pathologies.

Research Focus

Key Achievements

4
H-Index
4
Papers
109
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
The long-term oncological and functional outcomes of transoral robotic surgery in patients with hypopharyngeal cancer
48 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Yonsei University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago